U.S. markets close in 4 hours 39 minutes
  • S&P 500

    4,140.58
    -47.85 (-1.14%)
     
  • Dow 30

    34,234.47
    -508.35 (-1.46%)
     
  • Nasdaq

    13,320.20
    -81.66 (-0.61%)
     
  • Russell 2000

    2,181.02
    -31.68 (-1.43%)
     
  • Crude Oil

    64.82
    -0.10 (-0.15%)
     
  • Gold

    1,829.10
    -8.50 (-0.46%)
     
  • Silver

    27.49
    -0.01 (-0.03%)
     
  • EUR/USD

    1.2170
    +0.0035 (+0.29%)
     
  • 10-Yr Bond

    1.6250
    +0.0230 (+1.44%)
     
  • GBP/USD

    1.4148
    +0.0026 (+0.19%)
     
  • USD/JPY

    108.4970
    -0.3440 (-0.32%)
     
  • BTC-USD

    56,069.63
    -1,336.09 (-2.33%)
     
  • CMC Crypto 200

    1,495.20
    +1,252.52 (+516.12%)
     
  • FTSE 100

    6,923.95
    -199.73 (-2.80%)
     
  • Nikkei 225

    28,608.59
    -909.71 (-3.08%)
     

MedTech Round Up: Update On Products By Conformis, Medtronic, Orthofix, Neovasc

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
Vandana Singh
·2 min read
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

The FDA has given 510(k) clearance for Conformis Inc's (NASDAQ: CFMS) Identity Imprint Knee Replacement System, available in both cruciate-retaining (CR) and posterior stabilized (PS) versions.

  • Identity Imprint utilizes a proprietary 3-dimensional "best-fit" algorithm to select the implant that most closely meets the geometric and anatomic requirements of the patient based on the patient's computed tomography scans.

  • Price Action: CFMS shares are trading 6.95% higher at $0.90 during the market trading session on the last check Monday.

Medtronic plc (NYSE: MDT) has announced the U.S. commercial launch of the SonarMed airway monitoring system, a pediatric monitor to check endotracheal tube (ETT) obstruction and verify position in real-time.

  • SonarMed, which Medtronic acquired in December 2020, specializes in developing solutions that increase patient safety while significantly decreasing healthcare costs.

  • Price Action: MDT shares are up 0.43% at $127.24 during the market trading session on the last check Monday.

The FDA has given 510(k) clearance to Orthofix Medical Inc's (NASDAQ: OFIX) OrthoNext digital platform, a software tool for deformity analysis and preoperative planning for pediatric orthopedic procedures.

  • Developed specifically for use with the JuniOrtho Plating System, the OrthoNext digital platform software enables the surgeon to plan the osteotomy position accurately to visualize the implant concerning the anatomy.

  • The company has initiated its U.S. and European full market launch of the JuniOrtho Plating System.

  • Price Action: OFIX shares are down 4.05% at $42.37 during the market trading session on the last check Monday.

Neovasc Inc (NASDAQ: NVCN) has enrolled the first patient in the COSIMA trial investigating the company's Reducer for the treatment of Microvascular Angina.

  • The study will enroll up to 144 patients across multiple centers in Germany. The primary endpoint of the study is the change in CCS angina class, a measure of chest pain severity and limitation, by two or more classes.

  • The Reducer is CE-marked in the European Union to treat refractory angina, a painful and debilitating condition that occurs when the coronary arteries deliver an inadequate supply of blood to the heart muscle.

  • Price Action: NVCN shares are down 3.2% at $0.83 during the market trading session on the last check Monday.

See Benzinga's FDA Calendar

See more from Benzinga

© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.